ABOUT THE PRODUCT
Our proprietary platform, APPRAISE (Actionable PolyPharmacy Risk Assessment Index for Safety and Efficacy), analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to provide a unique and comprehensive risk assessment, individualized down to the DNA. It’s used to optimize drug regimens, reduce polypharmacy, and lower medical expenses.
Information is owner-confirmed
Last updated 1 month ago
Price range
Other products/services from GalenusRx
Lifesaving Insights™ Consulting Service
Biotechnology
N/A
GalenusRx
United States (US)